Oscar Health, Inc. OSCR
We take great care to ensure that the data presented and summarized in this overview for Oscar Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSCR
View all-
Vanguard Group Inc Valley Forge, PA18.4MShares$249 Million0.01% of portfolio
-
Black Rock Inc. New York, NY14.2MShares$191 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.7MShares$157 Million0.15% of portfolio
-
Dragoneer Investment Group, LLC San Francisco, CA9.49MShares$128 Million4.25% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY7.85MShares$106 Million3.1% of portfolio
-
Viking Global Investors LP6.17MShares$83.3 Million0.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$72.7 Million0.01% of portfolio
-
State Street Corp Boston, MA5.13MShares$69.3 Million0.0% of portfolio
-
Thrive Capital Management, LLC New York, NY4.76MShares$64.2 Million10.05% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.47MShares$60.3 Million0.02% of portfolio
Latest Institutional Activity in OSCR
Top Purchases
Top Sells
About OSCR
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Transactions at OSCR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 06
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,939
-1.6%
|
$479,024
$16.23 P/Share
|
Dec 06
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
16,793
-1.9%
|
$268,688
$16.23 P/Share
|
Dec 05
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+6.21%
|
-
|
Dec 05
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+6.53%
|
-
|
Dec 02
2024
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,078
-2.62%
|
$145,404
$18.28 P/Share
|
Dec 02
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,279
-1.39%
|
$455,022
$18.28 P/Share
|
Dec 02
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
26,895
-3.04%
|
$484,110
$18.28 P/Share
|
Dec 02
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
19,157
-3.68%
|
$344,826
$18.28 P/Share
|
Dec 02
2024
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
6,516
-3.69%
|
$117,288
$18.28 P/Share
|
Dec 02
2024
|
Steven Wolin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
19,580
-8.04%
|
$352,440
$18.28 P/Share
|
Dec 01
2024
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,318
+2.82%
|
-
|
Dec 01
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,245
+1.92%
|
-
|
Dec 01
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,047
+3.66%
|
-
|
Dec 01
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,738
+5.25%
|
-
|
Dec 01
2024
|
Mario Schlosser President of Technology & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,412
+14.01%
|
-
|
Dec 01
2024
|
Steven Wolin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,464
+5.13%
|
-
|
Nov 21
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.55%
|
$1,600,000
$16.86 P/Share
|
Nov 21
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.55%
|
$1,600,000
$16.86 P/Share
|
Nov 20
2024
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
88,395
+1.4%
|
$1,414,320
$16.97 P/Share
|
Nov 20
2024
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
88,395
+1.4%
|
$1,414,320
$16.97 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 3.25M shares |
---|---|
Grant, award, or other acquisition | 129K shares |
Open market or private purchase | 3.18M shares |
Open market or private sale | 968K shares |
---|